Published in Urology on December 01, 1989
Prognostic features and markers for testicular cancer management. Indian J Urol (2010) 1.00
High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy. World J Urol (2009) 0.89
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists. Histopathology (2015) 0.75
Some Observations on Chitin-destroying Bacteria. J Bacteriol (1932) 14.82
A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54
Studies of Freshwater Bacteria: II. Stalked Bacteria, a New Order of Schizomycetes. J Bacteriol (1935) 7.31
Methane emissions from cattle. J Anim Sci (1995) 5.59
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
Mechanism of insect resistance to the microbial insecticide Bacillus thuringiensis. Science (1990) 4.89
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother (1993) 4.76
American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin (2001) 4.41
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res (1994) 4.32
Signalling by receptor tyrosine kinases. Annu Rev Biochem (1993) 4.11
Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer (1977) 4.07
Medical evaluation of internationally adopted children. N Engl J Med (1991) 3.84
Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science (1989) 3.83
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A (2000) 3.44
Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst (1998) 3.17
Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst (1997) 3.03
Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol (1994) 3.00
Primary mucinous adenocarcinoma of the lung with signet-ring cells: a histochemical comparison with signet-ring cell carcinomas of other sites. Hum Pathol (1989) 2.97
Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol (2001) 2.91
Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol (1990) 2.88
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol Microbiol (1993) 2.80
Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun (2001) 2.62
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol (2001) 2.56
Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56
Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol (1998) 2.49
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A (1991) 2.48
Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer (1991) 2.41
Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A (1990) 2.34
Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res (1986) 2.30
Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med (1996) 2.29
Metastases from transitional cell carcinoma of urinary bladder. Urology (1980) 2.24
Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol (2002) 2.18
Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet (1983) 2.14
Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst (2001) 2.13
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun (1990) 2.12
Sarcomatoid renal cell carcinoma. A treatable entity. Cancer (1987) 2.12
The growing teratoma syndrome. Cancer (1982) 2.09
Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci (2000) 2.03
Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res (1997) 2.02
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. J Clin Oncol (1983) 2.01
The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys (1995) 2.00
Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol (1999) 1.99
Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. J Natl Cancer Inst (1996) 1.99
Fibrous dysplasia and cemento-ossifying fibroma. A histologic spectrum. Am J Surg Pathol (1995) 1.98
Combat casualties in Northern Thailand: emphasis on land mine injuries and levels of amputation. Mil Med (1981) 1.94
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol (2000) 1.93
CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res (2001) 1.92
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J Clin Oncol (1990) 1.91
Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun (1994) 1.91
Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer (1987) 1.90
Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol (2001) 1.88
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res (1991) 1.87
The diagnostic utility of desmin. A study of 584 cases and review of the literature. Am J Clin Pathol (1990) 1.86
Lymphoepithelioma-like carcinoma of the urinary bladder. Am J Surg Pathol (1994) 1.85
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res (1998) 1.83
c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol (1995) 1.83
Intra-abdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol (1993) 1.80
Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol (1992) 1.77
Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med (1995) 1.76
K-12 enrollment forecasting: merging methods and judgment. ERS Spectr (1998) 1.76
Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun (1991) 1.72
Allergic fungal sinusitis. Report of three cases associated with dematiaceous fungi. Am J Clin Pathol (1991) 1.70
Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect Immun (1996) 1.69
Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res (1995) 1.68
Improving the measurement of temporal change in regression models used for county population estimates. Demography (1984) 1.67
Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol (1987) 1.66
Squamous cell carcinoma of renal pelvis. Urology (1985) 1.66
Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer (2000) 1.63
Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys (2003) 1.63
Hemolytic reaction of clinical and environmental strains of Vibrio vulnificus. J Clin Microbiol (1981) 1.62
Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg (1997) 1.62
Fine-needle aspiration cytology of a case of oncocytic adrenocortical carcinoma. Diagn Cytopathol (2000) 1.61
Primary synovial sarcoma of the kidney. Am J Surg Pathol (2000) 1.61
Coagulase-negative staphylococcal septicemia: experience in a newborn intensive care unit. J Pediatr (1982) 1.60
Fibrin glue for partial nephrectomy. Urology (1991) 1.59
Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder. Hum Pathol (1995) 1.59
Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations. J Clin Oncol (1999) 1.58
Enlargement of the supraclavicular lymph nodes as the initial sign of prostatic carcinoma. Cancer (1971) 1.58
Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res (1994) 1.57
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer (1991) 1.57